Contact this trialFirst, we need to learn more about you.
TAK-079 for Multiple Myeloma
Recruiting2 awardsPhase 1
Houston, Texas
This trial is testing a new drug, TAK-079, for people with multiple myeloma who have already tried other treatments. The goal is to find the best dose of the new drug to give people, and to see how well it works and how safe it is.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service